海外の治験の状況「COVID-19」での検索結果
94件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Tumor Marker CA-19-9, CEA,CA125, CA242 for early diagnosis and predicting prognosis in gall bladder cancer patient
- Other specified diseases of gallbladder
- India
- 2019-03-13
Recruiting
- An open-label, single-center and single-arm clinical study of infusion of anti-CD19 or CD22 CAR-T cells (CT101A-19 or CT102A-22) for patients with relapsed/refractory/high risk B cell malignancies.
- B cell malignancies
- China
- 2019-06-18
Not recruiting
- Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- ALL, Childhood B-Cell
- China
- 2019-11-13
Recruiting
- Study to compare two formulations of pegfilgrastim in healthy males
- Healthy Human Volunteers, Age 18-45 years, BMI 19 to 25kg/m2
- India
- 2014-08-04
Not Recruiting
- Effect of ?3 on ppd test
- Tuberculosis. Tuberculosis;A15-19;Tuberculosis
- Iran (Islamic Republic of)
- 2015-11-27
Not Recruiting
- To evaluate the dermatological safety of hair oil and shampoo on women with sensitive scalp conditions.
- Total 35 female subjects, from 19 to 35 years (both inclusive) of age, with sensitive scalp condition were enrolled in the study.
- India
- 2018-01-19
Not recruiting
- Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation
- Non-small Cell Lung Cancer
- China
- 2009-04-01
Not Recruiting
- Targeting CD19 universal chimeric antigen receptor T cells (UCART-19 ) in refractory/relapsed B-cell acute lymphoblastic leukemia and aggressive lymphoma
- CD19 positive refractory/relapsed acute lymphoblastic leukemia
- China
- 2019-05-31
Not Recruiting
- Intervention program to increase colorectal cancer screening
- Colorectal cancer. Malignant neoplasm of colon and rectum;c-18, c-19;Malignant neoplasm of colon and rectum
- Iran (Islamic Republic of)
- 2015-06-28
Recruiting
- CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Acute Myeloid Leukemia
- China
- 2019-03-25
